Several evidences show that mutant p53 protein is one of the main players involved in radio/chemo-resistance insurgence and it generally predicts poor outcome and treatment failure in HNSCC patients [12–15]. This evidence concerns the gene TP53 and head and neck squamous cell carcinoma.